Article Cited by others

MOLECULES OF THE MILLENNIUM

Belimumab: First targeted biological treatment for systemic lupus erythematosus

Dubey Ashok K, Handu Shailendra S, Dubey Suparna, Sharma Prashant, Sharma K K, Ahmed Qazi M

Year : 2011| Volume: 2| Issue : 4 | Page no: 317-319

   This article has been cited by
 
1 Use of polyclonal/monoclonal antibody therapies in transplantation
Melissa Y. Yeung,Steven Gabardi,Mohamed H. Sayegh
Expert Opinion on Biological Therapy. 2017; : 1
[Pubmed]  [Google Scholar] [DOI]
2 TERAPIA BIOLÓGICA - BELIMUMABE NO LÚPUS ERITEMATOSO SISTÊMICO: REVISÃO SISTEMÁTICA DA LITERATURA
M.M. Santos,I.V.S. Lima
Revista Brasileira de Reumatologia. 2017; 57: S202
[Pubmed]  [Google Scholar] [DOI]
3 Genetics and novel aspects of therapies in systemic lupus erythematosus
Manfred Relle,Julia Weinmann-Menke,Eva Scorletti,Lorenzo Cavagna,Andreas Schwarting
Autoimmunity Reviews. 2015; 14(11): 1005
[Pubmed]  [Google Scholar] [DOI]
4 Tratamiento del lupus eritematoso sistémico: mitos, certezas y dudas
Guillermo Ruiz-Irastorza,Alvaro Danza,Munther Khamashta
Medicina Clínica. 2013;
[Pubmed]  [Google Scholar] [DOI]
5 Glomerulonephritis and vasculitis as causes of arterial hypertension [Glomerulonephritis und vaskulitis als ursachen einer arteriellen hypertonie]
Eicken, S. and Gugger, M. and Marti, H.-P.
Therapeutische Umschau. 2012; 69(5): 283-294
[Pubmed]  [Google Scholar]
6 Belimumab: New targeted therapeutic option for lupus erythematosus [Belimumab: Neue zielgerichtete therapieoption bei lupus erythematodes]
Gläser, R.
Hautarzt. 2012; 63(3): 253-255
[Pubmed]  [Google Scholar]
7 Belimumab
R. Gläser
Der Hautarzt. 2012; 63(3): 253
[Pubmed]  [Google Scholar] [DOI]

 

Read this article